Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients Enrolled in the Forte Trial
My City, My Style: Στεφανία Μακροπούλου - Savoir Ville
Stefania Alastre, MSPH, LCGC on LinkedIn: I was invited back on Despierta Tampa Bay this past August 15, 2022 to…
Stefi Gastaldi – SAI MedPartners
FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple myeloma - ecancer
Skin Cancer - The ASCO Post
May 25, 2021 - EPOV Stefania Scala - The ASCO Post
International Myeloma Foundation | IMF |Multiple Myeloma Information
Stefania COSTI | Researcher | PhD | Università degli Studi di Modena e Reggio Emilia, Modena | UNIMO | Surgical, Medical and Dental Department of Morphological Sciences related to Transplants Oncology and Regenerative Medicine | Research profile
A talk with the Centre Director and Centre Chair
Stefania Sanita - Co-Founder & Chief Operating Officer - ASK your Rx Inc. | LinkedIn